IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Birchview Capital, LP

Q1 2022 Holdings

Filed 2022-05-13 | 63 holdings | $10.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Albireo Pharma Inc(BDQM)COM01345P106$3.4K113,0000.0%
Foghorn Therapeutics Inc(FHTX)COM344174107$4.5K294,1430.0%
Quidel CorpCOM74838J101$6.7K59,6840.1%
Aziyo Biologics Inc(ELUT)COM05479K106$8.3K1,417,9230.1%
Neurocrine Biosciences Inc(NBIX)COM64125C109$8.4K89,2400.1%
Bristol-Myers Squibb Co(BMY)COM110122108$55.1K754,1060.5%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$325.0K20,0003.0%
Cullinan Oncology Inc(CGEM)COM230031106$472.0K45,1144.3%
Cytokinetics Inc(CYTK)COM23282W605$920.0K25,0008.4%
Arvinas Inc(ARVN)COM04335A105$1.0M15,0009.2%
Corcept Therapeutics Inc(CORT)COM218352102$1.1M50,00010.3%
Biogen Inc(BIIB)COM09062X103$2.1M10,10019.4%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$4.8M199,40044.2%
PreviousPage 2 of 2